Efficacy and safety of dulaglutide in patients with absolute insulin deficiency

Abstract

Objective. While dulaglutide has been approved inpatients with type 2 diabetes (T2DM) in combination with insulin, it has not been studied in insulin-deficient patients, not whether they have type 1 diabetes (T1DM) or T2DM. The aim of this study is to assess the efficacy and safety of dulaglutide 0.75 mg/once weekly (QW) in patients with absolute insulin deficiency (n=10).

Keywords

• glp-1 agonist
• dulaglutide
• type 1 diabetes
• insulin deficiency